Company Profile
Humana Stock Price, News & Analysis
- Ticker:
- HUM
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- United States
Stock performance
394.50 USD (-0.78%)
Close
Last updated: July 23, 2026
38.5B USD
Market cap
Why the stock is moving
HUM is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Humana is a managed-care company focused on Medicare Advantage, government-sponsored plans, and healthcare services. Its story is driven by membership, medical-cost trends, and the economics of senior healthcare rather than drug development.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Humana is a U.S.-focused healthcare benefits company with national scale. It sits in managed care rather than biotechnology.
Business Model Characteristics
The company makes money through premiums, care management, and healthcare services connected to its insurance base. Investors watch membership growth, benefit design, medical-cost ratios, and the performance of its government programs.
Position Within the Biotechnology Landscape
Humana is not a biotech name, but it is important to healthcare investors because it sits in the reimbursement and managed-care layer of the system. Its stock reacts to utilization, policy, and margin pressure instead of clinical data.
Future catalysts
Humana’s catalysts are earnings, Medicare Advantage pricing, and utilization trends that determine whether margin pressure improves or worsens. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast
BRKR · Source: Bruker
- 02
Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026
DGX · Source: Quest Diagnostics
- 03
Molina Healthcare Reports Second Quarter 2026 Financial Results
MOH · Source: Molina Healthcare
- 04
Axon to Release Second Quarter 2026 Earnings on August 5, 2026
AXON · Source: Axon Enterprise, Inc.
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Humana (HUM)?
Humana (HUM) most recently closed at 394.50 USD, a -0.78% move versus the previous session.
What is the market cap of Humana (HUM)?
Humana currently has a market capitalization of 38.5B USD on BioPharmSignal.
What does Humana do?
Humana is a managed-care company focused on Medicare Advantage, government-sponsored plans, and healthcare services. Its story is driven by membership, medical-cost trends, and the economics of senior healthcare rather than drug development.
On which exchange is HUM stock listed?
Humana (HUM) is associated with NYSE, United States, Biopharma.
What is Humana?
Humana’s catalysts are earnings, Medicare Advantage pricing, and utilization trends that determine whether margin pressure improves or worsens.
Which conditions is Humana targeting with Humana?
Humana’s catalysts are earnings, Medicare Advantage pricing, and utilization trends that determine whether margin pressure improves or worsens.
How does Humana describe recent progress with Humana?
Humana’s catalysts are earnings, Medicare Advantage pricing, and utilization trends that determine whether margin pressure improves or worsens.
What is Medicare?
Humana is a managed-care company focused on Medicare Advantage, government-sponsored plans, and healthcare services.